老年人潜在不适当处方的 STOPP/START 标准:第 3 版。

STOPP/START criteria for potentially inappropriate prescribing in older people: version 3.

机构信息

Department of Medicine (Geriatric Medicine), School of Medicine, University College Cork, Cork, Ireland.

Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, Ireland.

出版信息

Eur Geriatr Med. 2023 Aug;14(4):625-632. doi: 10.1007/s41999-023-00777-y. Epub 2023 May 31.

Abstract

PURPOSE

STOPP/START is a physiological systems-based explicit set of criteria that attempts to define the clinically important prescribing problems relating to potentially inappropriate medications (PIMs-STOPP criteria) and potential prescribing omissions (PPOs-START criteria). The previous two versions of STOPP/START criteria were published in 2008 and 2015. The present study describes the revised and updated third version of the criteria.

METHODS

A detailed system-by-system review of the published literature from April 2014 to March 2022 was undertaken with the aim of including clinically important new explicit PIM and PPO criteria and removing any criteria considered to be no longer correct or outdated. A panel of 11 academic physicians with recognized expertise in geriatric pharmacotherapy from 8 European countries participated in a Delphi panel with the task of validating the draft criteria. The panel was presented with the draft new criteria using the SurveyMonkey® on-line platform in which panelists were asked to indicate their level of agreement on a five-point Likert scale.

RESULTS

Two hundred and four evidence-based draft criteria (one hundred and forty-five STOPP criteria, fifty-nine START criteria) were presented to panelists for assessment using the Delphi validation method. Over the course of four rounds of Delphi validation, the panel achieved consensus on 133 STOPP criteria and 57 START criteria, i.e., 190 STOPP/START criteria in total representing a 66.7% increase in the number of criteria compared to STOPP/START version 2 published in 2015.

CONCLUSION

A fully revised and updated version of STOPP/START criteria has been validated by a European expert panel using the Delphi consensus process.

摘要

目的

STOPP/START 是一组基于生理系统的明确标准,旨在定义与潜在不适当药物(STOPP 标准中的潜在不适当药物 (PIM))和潜在药物遗漏(START 标准中的潜在处方遗漏 (PPO))相关的临床重要处方问题。STOPP/START 标准的前两个版本分别于 2008 年和 2015 年发布。本研究描述了该标准的修订和更新的第三版。

方法

从 2014 年 4 月至 2022 年 3 月,对已发表的文献进行了详细的系统审查,旨在纳入具有临床重要性的新的明确 PIM 和 PPO 标准,并删除任何被认为不再正确或过时的标准。来自 8 个欧洲国家的 11 名具有老年药理学专业知识的学术医生组成了一个专家小组,参与了一项 Delphi 小组的验证工作。小组使用 SurveyMonkey®在线平台提交了新的标准草案,小组成员被要求在 5 分制的李克特量表上对标准草案表示同意程度。

结果

使用 Delphi 验证方法,向小组成员提交了 204 条基于证据的标准草案(145 条 STOPP 标准,59 条 START 标准)进行评估。经过四轮 Delphi 验证,小组就 133 条 STOPP 标准和 57 条 START 标准达成共识,即总共 190 条 STOPP/START 标准,与 2015 年发布的 STOPP/START 第 2 版相比,标准数量增加了 66.7%。

结论

使用 Delphi 共识过程,欧洲专家组对 STOPP/START 标准的完全修订和更新版本进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f36/10447584/1bf89fa9be43/41999_2023_777_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索